TBPH 经营现金流历史(2016–2025)
THERAVANCE BIOPHARMA, INC. (TBPH) 年度经营现金流历史(来自 SEC 财报)—— 每个财年经营活动产生的现金净额。
$238.5MFY2025 · FY2016 以来:-$99.0M → $238.5M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $238.5M | +2168.0% |
| FY2024 | -$11.5M | +57.3% |
| FY2023 | -$27.0M | +85.6% |
| FY2022 | -$187.0M | +10.0% |
| FY2021 | -$207.9M | +17.0% |
| FY2020 | -$250.4M | -5.1% |
| FY2019 | -$238.2M | -111.0% |
| FY2018 | -$112.9M | +43.9% |
| FY2017 | -$201.1M | -103.1% |
| FY2016 | -$99.0M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议